Lucid Diagnostics Inc. (LUCD)
USD 1.5
(2.04%)
USD 1.5
(2.04%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 42.43 Million USD | -19.84% |
| 2022 | 52.93 Million USD | 93.66% |
| 2021 | 27.33 Million USD | 230.14% |
| 2020 | 8.27 Million USD | 87.3% |
| 2019 | 4.42 Million USD | 292.62% |
| 2018 | 1.12 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 10.32 Million USD | 7.15% |
| 2024 Q1 | 9.63 Million USD | -7.41% |
| 2023 Q3 | 10.27 Million USD | 0.81% |
| 2023 Q4 | 10.4 Million USD | 1.26% |
| 2023 FY | 42.43 Million USD | -19.84% |
| 2023 Q1 | 13.42 Million USD | 0.02% |
| 2023 Q2 | 10.19 Million USD | -24.07% |
| 2022 Q3 | 12.79 Million USD | -12.48% |
| 2022 Q2 | 14.62 Million USD | 22.72% |
| 2022 FY | 52.93 Million USD | 93.66% |
| 2022 Q1 | 11.91 Million USD | 7.36% |
| 2022 Q4 | 13.42 Million USD | 4.87% |
| 2021 Q2 | 6.01 Million USD | 64.69% |
| 2021 FY | 27.33 Million USD | 230.14% |
| 2021 Q4 | 11.09 Million USD | 69.06% |
| 2021 Q3 | 6.56 Million USD | 9.13% |
| 2021 Q1 | 3.65 Million USD | 33.78% |
| 2020 Q1 | 2.21 Million USD | 0.0% |
| 2020 Q4 | 2.73 Million USD | 35.07% |
| 2020 Q3 | 2.02 Million USD | 54.35% |
| 2020 FY | 8.27 Million USD | 87.3% |
| 2020 Q2 | 1.3 Million USD | -40.93% |
| 2019 FY | 4.42 Million USD | 292.62% |
| 2018 Q4 | 1.06 Million USD | 0.0% |
| 2018 FY | 1.12 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -278.047% |
| Cerus Corporation | 143.15 Million USD | 70.359% |
| OrthoPediatrics Corp. | 137.01 Million USD | 69.032% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -273.493% |
| Talis Biomedical Corporation | 67.18 Million USD | 36.844% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -70.095% |
| Inogen, Inc. | 236.08 Million USD | 82.027% |
| Spectral AI, Inc. | 20.86 Million USD | -103.374% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 24.225% |
| CVRx, Inc. | 76.14 Million USD | 44.273% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1102.722% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -239.755% |
| Orthofix Medical Inc. | 667.42 Million USD | 93.642% |
| Venus Concept Inc. | 80.47 Million USD | 47.274% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 25.003% |
| Bioventus Inc. | 409.91 Million USD | 89.649% |
| BrainsWay Ltd. | 28.01 Million USD | -51.445% |
| Envoy Medical, Inc. | 17.89 Million USD | -137.077% |
| electroCore, Inc. | 32.03 Million USD | -32.472% |
| IceCure Medical Ltd | 16.87 Million USD | -151.434% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -140.639% |
| MaxCyte, Inc. | 84.84 Million USD | 49.989% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -241.869% |
| Nexalin Technology, Inc. | 5.78 Million USD | -633.945% |
| PAVmed Inc | 64.82 Million USD | 34.546% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 16.927% |
| RxSight, Inc. | 103.85 Million USD | 59.141% |
| Sight Sciences, Inc. | 126.44 Million USD | 66.443% |
| SI-BONE, Inc. | 156.35 Million USD | 72.861% |
| TELA Bio, Inc. | 84.18 Million USD | 49.598% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 39.431% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 79.135% |
| LivaNova PLC | 843.54 Million USD | 94.97% |
| 908 Devices Inc. | 68.08 Million USD | 37.673% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 91.226% |
| Nemaura Medical Inc. | 7.13 Million USD | -494.385% |
| NeuroPace, Inc. | 75.29 Million USD | 43.646% |
| LENSAR, Inc. | 33.33 Million USD | -27.286% |
| Apyx Medical Corporation | 51.01 Million USD | 16.829% |
| Cutera, Inc. | 197.72 Million USD | 78.54% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -71.228% |
| BioSig Technologies, Inc. | 28.53 Million USD | -48.728% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 77.839% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -17.671% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 94.927% |
| Axonics, Inc. | 270.2 Million USD | 84.296% |
| Outset Medical, Inc. | 198.77 Million USD | 78.653% |
| IRIDEX Corporation | 31.81 Million USD | -33.375% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 76.455% |
| IRadimed Corporation | 30.12 Million USD | -40.863% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -397.328% |
| INVO Bioscience, Inc. | 7.85 Million USD | -440.308% |
| Telesis Bio, Inc. | 63.48 Million USD | 33.166% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 56.901% |
| Varex Imaging Corporation | 224.8 Million USD | 81.125% |
| Quipt Home Medical Corp. | 148.66 Million USD | 71.458% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -261.955% |
| Pulmonx Corporation | 112.68 Million USD | 62.345% |
| Dynatronics Corporation | 9.9 Million USD | -328.259% |
| Modular Medical, Inc. | 17.52 Million USD | -142.067% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -110.195% |
| Semler Scientific, Inc. | 38.94 Million USD | -8.956% |
| InMode Ltd. | 215.68 Million USD | 80.326% |
| Bruker Corporation | 1.07 Billion USD | 96.058% |
| Cytosorbents Corporation | 48.33 Million USD | 12.216% |
| DexCom, Inc. | 1.69 Billion USD | 97.491% |
| Align Technology, Inc. | 2.07 Billion USD | 97.957% |
| Viveve Medical, Inc. | 22.17 Million USD | -91.368% |
| ZimVie Inc. | 275.12 Million USD | 84.577% |
| Movano Inc. | 29.69 Million USD | -42.917% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 69.089% |
| Nexalin Technology, Inc. | 5.78 Million USD | -633.945% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1102.722% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 92.939% |
| Profound Medical Corp. | 33.6 Million USD | -26.274% |
| Insulet Corporation | 939.9 Million USD | 95.485% |
| enVVeno Medical Corporation | 25.23 Million USD | -68.127% |
| Surmodics, Inc. | 98.69 Million USD | 57.008% |
| iCAD, Inc. | 22.22 Million USD | -90.92% |
| Nuwellis, Inc. | 22.61 Million USD | -87.644% |
| Biotricity, Inc. | 17.18 Million USD | -146.919% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 90.484% |
| Aethlon Medical, Inc. | 12.27 Million USD | -245.608% |
| InspireMD, Inc. | 22.95 Million USD | -84.889% |
| PAVmed Inc. | 64.82 Million USD | 34.546% |
| BIOLASE, Inc. | 34.66 Million USD | -22.42% |
| Beyond Air, Inc. | 61.7 Million USD | 31.229% |
| FONAR Corporation | 28.6 Million USD | -48.339% |
| AxoGen, Inc. | 149.33 Million USD | 71.586% |
| Vivani Medical, Inc. | 26.96 Million USD | -57.36% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 76.04% |
| Inari Medical, Inc. | 448.59 Million USD | 90.541% |
| UFP Technologies, Inc. | 58.08 Million USD | 26.953% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -761.109% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -571.574% |
| Tenon Medical, Inc. | 16.96 Million USD | -150.071% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -473.948% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 3.789% |
| AdaptHealth Corp. | 1.07 Billion USD | 96.064% |
| Sintx Technologies, Inc. | 15.2 Million USD | -179.14% |
| NanoVibronix, Inc. | 4.97 Million USD | -753.248% |
| Quanterix Corporation | 118.1 Million USD | 64.071% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -261.955% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -193.81% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 89.194% |
| TransMedics Group, Inc. | 182.82 Million USD | 76.79% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -51.192% |
| NeuroMetrix, Inc. | 11.09 Million USD | -282.307% |
| Hyperfine, Inc. | 52.87 Million USD | 19.746% |
| Establishment Labs Holdings Inc. | 172 Million USD | 75.331% |
| Biomerica, Inc. | 6.97 Million USD | -508.083% |
| Bone Biologics Corporation | 9.42 Million USD | -350.049% |
| AVITA Medical, Inc. | 80.77 Million USD | 47.472% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -311.513% |
| Silk Road Medical, Inc | 186.35 Million USD | 77.231% |